We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
IS Pharma | LSE:ISPH | London | Ordinary Share | GB00B2QBY649 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 87.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/3/2010 17:22 | Perhaps to ISPH Isoplex and Volplex were low profit margin - but to the right company with synergies and or the determination to grow market share or for cross-selling this would have been a nice earner, so logically it wouldn't necessarily be "many" years of profit for a ROI to a potential purchaser and the sale should have been priced as such. I don't disagree that a disposal wasn't flagged up some time ago, nor that it wasn't the wrong thing to do from a strategy perspective (i.e. get rid of non-core), but £1.4m represents a bad price for decent assets and accepting a bad price leads to justified criticism and speculation. Until I see evidence that it was the best price possible .... etc., etc. | gogoneko | |
24/3/2010 16:40 | Well said Clogue | red ninja | |
24/3/2010 13:42 | Carwhite - which was? | the_hedge | |
24/3/2010 12:36 | clogue - 24 Mar'10 - 10:12 - 208 of 208 I think you just answered your own question. | carwhite | |
24/3/2010 10:12 | The sale of Isoplex and Volplex was a very good deal. These products were in a mature market that was dominated by big players(not where ispharma wants to be)and were subject to strong pricing pressure. The £1.4m represents one year's sales but given the low profit margin this represented many years profit. Episil is an oncology supportive care product and obviously fits in well with other products sold by the company and is at a stage that it can be developed and sales increased. The fact that no details were given as to the purchaser of Isoplex means that there is no connection (of any kind) between any employee of the company and the company buying. As I have said before I am very happy to hold these shares and I have every confidence in the management and their business model. Although I personally have no concerns I would like to hear of any genuine, substantiated, information that would make me change my mind. | clogue | |
22/3/2010 13:55 | Why do you guys think the share price keeps falling back. The market is fully aware of the management. | carwhite | |
22/3/2010 10:34 | "prudent book balancing"?! Throw-away sale of a profitable business as a desperate measure prior to year-end results accounting in order to flatter headline figures to boost the share price more like! Where were the princely valuation techniques for Isoplex and Volplex which they applied in their earlier mates-rate acquisitions of SEPI AG and Acorus? | gogoneko | |
22/3/2010 10:04 | At the time of the last results we were told that Volplex and Isoplex were being run down and they were concentrating on "our most profitable and sustainable products". The company has recently bought the european right to market Episil and it looks like this is just a bit of prudent book balancing. Management are doing exactly what I expect of them and I see no reason to doubt their ability to manage, do deals and grow the company. If I lose faith in this management I will simply sell and move on, as this is the only logical step I can take as a private investor, but I have seen nothing that is giving me second thoughts. | clogue | |
22/3/2010 07:54 | £1.4m for Volplex and Isoplex, that's pathetic! A considerable amount of shareholder cash was spent on developing and marketing these products successfully and profitably.... and they've been given away for £1.4m!?! I'd like to know who to and how well they know the management! This lot certainly know how to splash out wads and dilute existing shareholders to almost nothing when they want to buy in stuff, but when want to pass on part of the existing portfolio they practically give it away. | gogoneko | |
16/3/2010 20:16 | Not really interest in the herd mentality thanks, I type the way I feel. Looking forward to topping ISPH at 5p old money I initially bought at 6.5p | carwhite | |
16/3/2010 20:05 | Carwhite, you might like to cast an eye or two over when you get the chance, wonderful though the net is, it still falls over when trying to convey sentiment through typing. As for the visually impaired, web browsers (yes, even those that still use Internet Explorer) usually provide the ability to enlarge the text on the page, therefore writing in all uppercase probably won't help the situation, it'll just be in uppercase. Thanks again for your thoughts on ISPH though. Roll on results day. | the_hedge | |
16/3/2010 15:45 | only about share prices! | carwhite | |
16/3/2010 12:31 | I never knew you cared. | red ninja | |
15/3/2010 21:46 | no to date a right one. | carwhite | |
15/3/2010 18:25 | You were a scardey cat | red ninja | |
15/3/2010 18:07 | Why should I want to as I know it was coming back down! | carwhite | |
15/3/2010 17:06 | Well you didn't call anything when it was going up. Big silence | red ninja | |
15/3/2010 17:05 | exactimenti | carwhite | |
15/3/2010 17:01 | Que sera sera up or down or sideways. Your deramps will make no difference. | red ninja | |
15/3/2010 16:59 | 50p is calling now. | carwhite | |
13/3/2010 10:53 | Problem is that I am not common so don't accept that. All I accept on BBs is calling it right which I have do so here to date. | carwhite |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions